H. E. Kaiser

527 citations
29 papers · 453 · h-index 12

Impact in

Papers in

    • Cancer Cells and Metastasis 6
    • Cancer Immunotherapy and Biomarkers 2
    • Glioma Diagnosis and Treatment 4

H. E. Kaiser

27 papers receiving 432 citations

Peers

H. E. Kaiser
Comparison fields: 5 of 51
  • Endocrinology, Diabetes and Metabolism 82
  • Genetics 38
  • Immunology 72
  • Hepatology 32
  • Oncology 74
Replace Seham Skah with:
Seham Skah France
Takaomi Okawa Japan
Kristie I. Aamodt United States
Changyoung Yoo South Korea
Yichun Yang China
Jeffrey A. Ucran United States
Ide T Japan
Chiara Gregorj Italy
Massimo Statuto Italy
W Wang China
H. E. Kaiser relative to Seham Skah France Seham Skah's profile →
Citations per field
00.5×5×12×
Seham Skah · 1×
Citations per year

Countries citing papers authored by H. E. Kaiser

Since Specialization
Citations

This map shows the geographic impact of H. E. Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. E. Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. E. Kaiser more than expected).

Fields of papers citing papers by H. E. Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. E. Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. E. Kaiser. The network helps show where H. E. Kaiser may publish in the future.

Co-authors

The 25 scholars most cited alongside H. E. Kaiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. E. Kaiser Line = papers co-authored together H. E. Kaiser links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
199757
2 200153
3
Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma.
199847
4
Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy.
199836
5
Papillary microcarcinoma of the thyroid: a clinico-pathologic and prognostic review.
200036
6
Apoptosis and pathogenesis of viral hepatitis C--an update.
200036
7
Novel insights into the function of the thymic Hassall's bodies.
200036
8
Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors.
200031
9
Development of Hassall's bodies of the thymus in humans and other vertebrates (especially mammals) under physiological and pathological conditions: immunocytochemical, electronmicroscopic and in vitro observations.
199726
10
Value of multilevel sectioning for improved detection of micrometastases in sentinel lymph nodes in invasive squamous cell carcinoma of the vulva.
200421
11
Identification of neural crest derived cells within the cellular microenvironment of the human thymus employing a library of monoclonal antibodies raised against neuronal tissues.
199615
12
Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors.
200012
13
Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
20018
14
Advances in the understanding of lung cancer.
19976
15
Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression.
19976
16 19895
17
Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
19975
18 19893
19 19893
20 19892

About H. E. Kaiser

H. E. Kaiser is a scholar working on Oncology, Genetics, Immunology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 29 papers that have together received 453 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Veterinary Oncology Research (4 papers), T-cell and B-cell Immunology (4 papers), Glioma Diagnosis and Treatment (4 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Multiple and Secondary Primary Cancers (2 papers) and Developmental Biology and Gene Regulation (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (82 citations), Genetics (38 citations), Immunology (72 citations), Hepatology (32 citations) and Oncology (74 citations). H. E. Kaiser has collaborated with scholars based in United States, Austria and Germany. Frequent co-authors include B Bödey, Stuart E. Siegel, Klaus Kaserer, N. Neuhold, A M Gröger, James V. Luck, C R Taylor, John T. Kemshead, Edward C. Grendys and James V. Fiorica. Their work appears in journals such as Endocrine Pathology, PubMed and Springer eBooks.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact